ELAB PMGC Holdings Inc.

NEUTRAL Impact: 4/10 PRESS-RELEASE
Horizon months Filed Jun 1, 2026 Processed 11d 21h ago Wire GlobeNewswire
Press release: m_and_a
Latest settled — T+5d
ELAB ▼ -12.99% at T+5d
NEUTRAL call ✗ call lost -12.99% · α vs SPY -10.24% · entry $1.77 → $1.54
Next anchor: T+20d in 17d
Currently $1.47 · -16.95% from $1.77 entry
Entry anchored
Jun 1, 05:04 AM ET
via Databento tick
T+1d
-5.08%
call -5.08% · α -5.23%
$1.68
settled 11d ago
T+5d
-12.99%
call -12.99% · α -10.24%
$1.54
settled 5d ago
T+20d
call — · α —
in 17d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

PMGC Holdings (ELAB) announced a non-binding LOI to acquire a 76% controlling interest in a privately held precision machining company for cash. The target generated $5.46M revenue and $1.05M EBITDA in FY2025, with over 20% EBITDA margins. The deal is subject to due diligence, audit, and definitive documentation; no purchase price was disclosed.

Actionable Insight

Monitor for definitive purchase agreement and funding details; the non-binding nature and need for audit create high risk of deal failure. Price action likely muted until more concrete terms emerge.

Key Facts

  • Non-binding LOI to acquire 76% of a precision machining company
  • Target had $5.46M revenue and $1.05M EBITDA in FY2025
  • Target's adjusted EBITDA margin >20% on trailing twelve months
  • Target is AS9100 compliant, ISO 9001:2015, ITAR registered
  • Acquisition consideration is cash, amount subject to due diligence
  • Expected closing before Q4 2026, contingent on audit and definitive agreement

Financial Impact

Target's EBITDA of $1.05M represents ~13% of PMGC's $8M market cap, but deal value and financing terms are undisclosed.

revenueebitdadilution

Risk Factors

  • Non-binding LOI may not lead to a definitive agreement
  • Deal value and financing terms unknown; potential for shareholder dilution if cash is raised
  • Audited financials may differ materially from unaudited figures provided

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3304257
19 reports for ELAB
Performance horizon
40% Hit rate 2 of 5 directional calls best @ T+20▲ +42.86%Apr 20, 2026
Filters
Rows
Reports for ELAB — sortable, filterable
Type Now
Jun 8, 2026
4d ago
Press Release
NEUTRAL ★ 4/10
$1.52 awaiting T+5awaiting T+5$1.47 (−3.29%)
Jun 5, 2026
7d ago
8-K
NEUTRAL ★ 4/10
$1.55 awaiting T+5awaiting T+5$1.47 (−5.16%)
Jun 1, 2026
11d ago
Press Release
NEUTRAL ★ 4/10
$1.77 $1.54▼ −12.99%▼ −10.24%$1.47 (−16.95%)
May 13, 2026
4w ago
8-K
MIXED ★ 7/10
$1.98 $1.75▼ −11.62%▼ −10.46%$1.47 (−25.76%)
May 13, 2026
4w ago
Press Release
NEUTRAL ★ 5/10
$1.98 $1.75▼ −11.62%▼ −10.46%$1.47 (−25.76%)
Apr 23, 2026
7w ago
8-K
MIXED ★ 6/10
$2.94 $2.53▼ −13.95%▼ −15.42%$1.47 (−50.00%)
Apr 23, 2026
7w ago
Press Release
NEUTRAL ★ 4/10
$2.94 $2.53▼ −13.95%▼ −15.42%$1.47 (−50.00%)
Apr 21, 2026
7w ago
8-K
BULLISH ★ 6/10
$3.29 $2.54▼ −22.80%▼ −23.88%$1.47 (−55.32%)
Apr 20, 2026
7w ago
424B5
BEARISH ★ 6/10
$3.29 $2.54▲ +22.80%▲ +23.88%$1.47 (+55.32%)
Apr 17, 2026
8w ago
8-K
MIXED ★ 6/10
$3.28 $2.49▼ −24.09%▼ −24.64%$1.47 (−55.18%)
Showing 10 of 19

US Market Status

Market Closed — Opens Mon (52h 20m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access